Analysts Offer Insights on Healthcare Companies: 4D Molecular Therapeutics (FDMT), Alcon ...
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on 4D Molecular Therapeutics (FDMT – Research ...
MSN による配信2 日
Alcon Stock Gains From Innovation Despite Macroeconomic Troubles
Alcon Inc. ALC gains on strong market share gains. The company’s broad pipeline and focus on research and innovation are ...
Alcon Announces U.S. Launch of Voyager DSLT, First-of-its-Kind Treatment for Glaucoma and ...
Alcon (SIX/NYSE: ALC), the global leader in eye care, dedicated to helping people see brilliantly, announced today the full U ...
ophthalmologytimes11 日
Alcon announces US launch of Voyager direct selective laser trabeculoplasty device
The first-line laser treatment for glaucoma and ocular hypertension will be unveiled at the 2025 American Glaucoma Society ...
ophthalmologytimes6 日
Alcon to launch new SYSTANE PRO PF dry eye relief
Alcon announced the US launch of SYSTANE PRO Preservative-Free (PF) as part of the company’s dry eye products. The ...
Healio3 日
VIDEO: Alcon highlights latest products, innovations at SECO
In this Healio Video Perspective from SECO 2025, Kristen Brotherson, general manager of U.S. vision care at Alcon, outlined the company’s latest eye care innovations being premiered at the meeting.